12 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
(“ASU 2021-04”), which aims to clarify and reduce diversity in issuer’s accounting for modifications or exchanges of freestanding equity-classified
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
and have an exercise price of US$9.02.
Board Diversity Matrix
The table below provides certain information with respect to the diversity of our Board
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
31 Mar 23
Report of Foreign Private Issuer
4:30pm
-04”), which aims to clarify and reduce diversity in issuer's accounting for modifications or exchanges of freestanding equity-classified written call
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
of US$9.02.
Board Diversity Matrix
The table below provides certain information with respect to the diversity of our Board of Directors
20-F/A
mwsqhsiuuy6hzwad8
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
EX-99.4
gdtp9qo oqxkm0
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.3
eyqqcnwtyyb6a0lwa
27 Mar 19
Securities Purchase Agreement
8:32am
- Prev
- 1
- Next